Literature DB >> 4568331

Augmenting the action of levodopa.

S K Rao, S D Vakil, D B Calne, A Hilson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4568331      PMCID: PMC2495330          DOI: 10.1136/pgmj.48.565.653

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  20 in total

1.  The pathogenesis of Parkinson's disease: a new hypothesis.

Authors:  A BARBEAU
Journal:  Can Med Assoc J       Date:  1962-10-13       Impact factor: 8.262

2.  Potentiation by amantadine hydrochloride of L-dopa-induced effects in mice.

Authors:  T H Svensson; U Strömberg
Journal:  J Pharm Pharmacol       Date:  1970-08       Impact factor: 3.765

3.  Modification of Parkinsonism--chronic treatment with L-dopa.

Authors:  G C Cotzias; P S Papavasiliou; R Gellene
Journal:  N Engl J Med       Date:  1969-02-13       Impact factor: 91.245

4.  Fusaric (5-butylpicolinic) acid, an inhibitor of dopamine beta-hydroxylase, affects serotonin and noradrenaline.

Authors:  H Hidaka
Journal:  Nature       Date:  1971-05-07       Impact factor: 49.962

5.  Therapeutic implications in Parkinsonism of m-tyramine formation from L-dopa in man.

Authors:  M Sandler; B L Goodwin; C R Ruthven
Journal:  Nature       Date:  1971-02-05       Impact factor: 49.962

6.  Action of L- -methyldopa-hydrazine on the blood pressure of patients receiving levodopa.

Authors:  D B Calne; A Petrie; S Rao; J L Reid; S D Vakil
Journal:  Br J Pharmacol       Date:  1972-01       Impact factor: 8.739

7.  Control of waste.

Authors: 
Journal:  Br Med J       Date:  1970-09-05

8.  L-dopa treatment failure: explanation and correction.

Authors:  L Rivera-Calimlim; C A Dujovne; J P Morgan; L Lasagna; J R Bianchine
Journal:  Br Med J       Date:  1970-10-10

9.  Amantadine in the treatment of Parkinson's disease.

Authors:  R S Schwab; A C England; D C Poskanzer; R R Young
Journal:  JAMA       Date:  1969-05-19       Impact factor: 56.272

Review 10.  Dopamine (3-hydroxytyramine) and brain function.

Authors:  O Hornykiewicz
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.